Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
HELP with high resolution image viewing | Return to article


Please click here to check whether you must obtain permission to reproduce this image.


Figure 1


Figure 1. Prescriptions for gabapentin, by diagnostic category.

Estimates of diagnosis-linked prescribing provided by Pfizer, Inc. (2–4). Each diagnosis was assigned to a diagnostic category by the authors. *Adjunctive treatment of epilepsy in adults older than age 12 years was the only U.S. Food and Drug Administration–approved use of gabapentin during the time period shown.





Return to article



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online